Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

Inclusion Criteria: * Body mass index of 19-29kg/m2, inclusive * Weight of 50-95kg, inclusive * Clinically normal physical findings and laboratory values including hepatitis B, hepatitis C, and HIV, as judged by the Investigator Exclusion Criteria: * Significant clinical illness within the 2 weeks preceding the first dose of investigational products, as judged by the Investigator * History of mental, cardiac, renal, hepatitis, neurological, or significant gastrointestinal disease, as judged by the Investigator * Condition which could modify the absorption of the investigational products, as judged by the Investigator